Contact Us

Tribal

AIM Vaccine's Serum-Free Iterative Rabies Vaccine Has Received Production License and Will Submit for Market Registration

Launch of Major Product Expected to Significantly Drive Performance Growth HONG KONG,March 12,2025-- AIM Vaccine Co.,Ltd. (06660.HK),a leading PRC vaccine company,published an announcement on March 12

Tribal

Mar 12, 2025

Ascletis Announces Positive Topline Results of Phase Ib Studies of ASC47 Monotherapy in Australia and U.S. FDA Clearance of IND Application for ASC47 in Combination with Semaglutide

ASC47,an adipose-targeted muscle-preserving weight loss drug candidate for the treatment of obesity,demonstrated a half-life of up to 26 days and 40 days,respectively,in Phase Ib single subcutaneous i

Tribal

Mar 12, 2025

Ericsson Annual Report on Form 20-F filed with the SEC

STOCKHOLM,March 12,2025-- On March 11,2025,Ericsson (NASDAQ: ERIC) filed its Annual Report on Form 20-F for the year ended December 31,2024,with the U.S. Securities and Exchange Commission (SEC).

Tribal

Mar 12, 2025

CGTN AMERICA & CCTV UN: China in Springtime - Sharing Opportunities with the World

WASHINGTON,March 8,2025-- CGTN America & CCTV UN releases "China in Springtime – Sharing Opportunities with the World."

Tribal

Mar 11, 2025

BEST Inc. Announces Completion of Going Private Transaction

HANGZHOU,China,March 8,2025-- BEST Inc. (NYSE: BEST) ("BEST" or the "Company"),a leading integrated smart supply chain solutions and logistics services provider in China and Southe

Tribal

Mar 11, 2025

Thai Scientists from Chula to Investigate Global Warming in Antarctica

BANGKOK,March 10,2025-- Prof. Dr.Suchana Chavanich from the Department of Marine Science,Faculty of Science,and Deputy Director of the Aquatic Resources Research Institute,Chulalongkorn University rec

Tribal

Mar 11, 2025
1 ... 39 40 41 42 43 44 45 ... 127